SCHEMBL30574392

SCHEMBL30574392

Cc1ccc(C)c(N2CCN(S(=O)(=O)c3ccc(O)c4ncccc34)CC2)c1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.69
▸ COMT P21964 4/20 0.63
▸ LMNA P02545 4/20 0.62
▸ KDM4E B2RXH2 3/20 0.62
▸ L3MBTL1 Q9Y468 3/20 0.62
▸ HTT P42858 3/20 0.62
▸ RAB9A P51151 2/20 0.62
▸ SMN1; SMN2 Q16637 2/20 0.62
▸ NPC1 O15118 1/20 0.62
▸ MITF O75030 1/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ TDP1 Q9NUW8 1/20 0.62
▸ POLB P06746 2/20 0.54
▸ USP2 O75604 1/20 0.51
▸ GAA P10253 2/20 0.51
▸ HSD17B10 Q99714 1/20 0.49
▸ MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17962379 1.00 ALDH1A1 (0.69) ALDH1A1COMTLMNAKDM4EL3MBTL1
SCHEMBL17962362 0.84 COMT (0.64) ALDH1A1COMTLMNAKDM4EL3MBTL1
SCHEMBL17962417 0.80 COMT (0.78) ALDH1A1COMTLMNAKDM4EL3MBTL1
SCHEMBL17962335 0.79 COMT (0.73) ALDH1A1COMTLMNAKDM4EHTT
SCHEMBL17962274 0.79 COMT (0.65) ALDH1A1COMTLMNAKDM4EL3MBTL1
SCHEMBL17960049 0.78 COMT (1.00) COMTKDM4ESMN1; SMN2
SCHEMBL17962384 0.78 COMT (0.64) ALDH1A1COMTLMNAKDM4EHTT
SCHEMBL17962361 0.78 COMT (0.64) ALDH1A1COMTLMNAKDM4EHTT
SCHEMBL17962271 0.77 KDM4E (1.00) ALDH1A1COMTKDM4ESMN1; SMN2
SCHEMBL17962265 0.76 COMT (0.68) ALDH1A1COMTLMNAKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3250209-B1 COMT INHIBITING METHODS AND COMPOSITIONS LIEBER INST FOR BRAIN DEVELOPMENT (US) 2023-09-13 — — EP claimed
EP-3250209-B1 COMT INHIBITING METHODS AND COMPOSITIONS LIEBER INST FOR BRAIN DEVELOPMENT (US) 2023-09-13 — — EP disclosed
Send feedback